Pakistan

in page functions
[French]
Pakistan
Total population (2018) 200,661,824
Birth cohort (2018) 5,482,686
Surviving Infants (surviving to 1 year per year, 2018) 5,138,779
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 81/1000
World Bank Index, IDA (2015) 3.22
Gross Nation Income (per capita US$, 2015) 1,440
No. of districts/territories (2017) 151

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Pakistan

Type of support

Approvals

2001-2023 (US$)
(2 Jul 2019)

Commitments

2001-2023 (US$)
(2 Jul 2019)

Disbursements

2000-2019 (US$)
(2 Jul 2019)

% Disbursed

(2 Jul 2019)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $1,389,204,613 $1,486,597,613 $1,296,679,798
Civil Society Organisation support (CSO) $7,638,649 $7,638,649 $7,738,649 101%
Cold Chain Equipment Optimisation Platform (CCEOP) $23,109,633 $23,109,633 $7,696,069 33%
Health system strengthening (HSS 1) $23,379,207 $23,379,207 $23,379,207 100%
Health system strengthening (HSS 2) $113,399,620 $113,399,620 $99,750,000 88%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $48,763,740 100%
Injection Safety Devices (NVS) $8,227,502 $10,091,502 $5,956,056 72%
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
IPV (NVS) $32,181,489 $32,181,489 $26,866,133 83%
Measles SIA (NVS) $10,029,548 $10,029,548 $10,029,548 100%
Measles SIA - Operational costs (OPC) $43,014,014 $43,014,014 $43,014,014 100%
Measles-Follow-up campaign (NVS) $10,593,909 $10,593,909 $10,593,909 100%
Penta (NVS) $387,329,394 $403,283,394 $395,262,527 102%
Pneumo (NVS) $471,086,105 $512,492,105 $477,061,895 101%
Product Switch Grant (PSG) $1,768,879 $1,768,879
Rotavirus (NVS) $46,647,000 $67,671,000 $41,354,133 89%
TCV (NVS) $7,158,000 $15,108,500 $1,174,920 16%
TCV-Catch up campaign (NVS) $50,529,000 $59,723,500 $18,936,010 37%
TCV-Catch-up campaign op.costs (OPC) $19,728,246 $19,728,246
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $20,874,538 $20,874,538 $15,356,848 74%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 75%
M:F sex ratio at birth (2018) 1.09
Household survey: DTP3 coverage for male (2012) 67.20%
Household survey: DTP3 coverage for female (2012) 63.10%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2017) 62%
% districts achieving < 50% DTP3 coverage (2017) 7%
MCV WHO/UNICEF estimates (2017) 76%

Breakdown of support

Non-vaccine support Vaccine support
20% 80%
$253,103,609 $1,043,576,189

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

09 May 2019

IPV

Inactivated polio vaccine now introduced worldwide

Momentous global effort enables record-breaking milestone for polio and immunisation.

12 March 2019

Gavi item

Gavi and Zenysis Technologies to bring data and artificial intelligence to immunisation programmes

The partnership supported by Asia’s largest internet services company Tencent will help developing countries reach more children with life-saving vaccines.

10 December 2018

MTR

UAE and Gavi convene leaders to focus on health for next generation

High-level meeting to review access to vaccines in low-income countries and how to accelerate impact.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here